Cargando…

Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls

BACKGROUND: Irritable bowel syndrome (IBS) is more common in patients with ulcerative colitis (UC) than expected. The prevalence of IBS in patients with UC with longstanding disease is not known. We investigated the prevalence of IBS-like symptoms in patients with UC in remission and longstanding di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lundgren, D., Rutegård, J., Eklöf, V., Palmqvist, R., Karling, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121960/ https://www.ncbi.nlm.nih.gov/pubmed/27881072 http://dx.doi.org/10.1186/s12876-016-0553-x

Ejemplares similares

Irritable bowel syndrome-like symptoms in treated microscopic colitis patients compared with controls: a cross-sectional study
por: Pagoldh, Jenny, et al.
Publicado: (2019)

Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health
por: Katinios, Georgios, et al.
Publicado: (2020)

DNA Aneuploidy in Ulcerative Colitis and in Colorectal Carcinoma – A Comparative Study
por: Stenling, Roger, et al.
Publicado: (1999)

Irritable bowel syndrome-like symptoms associated with endoscopic activity predict ulcerative colitis relapse in patients with clinical remission
por: Fukuba, Nobuhiko, et al.
Publicado: (2017)

Telomere shortening correlates to dysplasia but not to DNA aneuploidy in longstanding ulcerative colitis
por: Friis-Ottessen, Mariann, et al.
Publicado: (2014)

Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis
por: Baumgartner, Maximilian, et al.
Publicado: (2021)

Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota
por: Noor, Samah O, et al.
Publicado: (2010)

Do Patients With Irritable Bowel Syndrome Exhale More Hydrogen Than Healthy Subjects in Fasting State?
por: Choi, Chang Hwan
Publicado: (2010)

Cancer‐associated fecal microbial markers in colorectal cancer detection
por: Eklöf, Vincy, et al.
Publicado: (2017)

Differential diagnosis of ulcerative colitis with increased diarrhea; collagenous colitis or irritable bowel syndrome? A case report
por: Haraikawa, Mayuko, et al.
Publicado: (2022)

A186 ASSOCIATION OF ULCERATIVE COLITIS BOWEL URGENCY IMPROVEMENT WITH CLINICAL RESPONSE AND REMISSION
por: Clemow, D B, et al.
Publicado: (2023)

Do Patients With Irritable Bowel Syndrome Exhale More Hydrogen Than Healthy Subjects in Fasting State?: Author's Reply
por: Ghoshal, Uday C, et al.
Publicado: (2010)

Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome
por: Kalantari, Hamid, et al.
Publicado: (2015)

Therapeutic Potential of Proanthocyanidins in Ulcerative Colitis in Remission
por: Głąbska, Dominika, et al.
Publicado: (2020)

Transcriptional Signatures That Define Ulcerative Colitis in Remission
por: Fenton, Christopher G, et al.
Publicado: (2020)

Patient-reported and doctor-reported symptoms when faecal immunochemical tests are requested in primary care in the diagnosis of colorectal cancer and inflammatory bowel disease: a prospective study
por: Högberg, Cecilia, et al.
Publicado: (2020)

Why Do Irritable Bowel Syndrome Women Often Have Nausea Symptom?
por: Chang, Full-Young
Publicado: (2012)

Flow cytometric DNA ploidy pattern in dysplastic mucosa, and in primary and metastatic carcinomas in patients with longstanding ulcerative colitis.
por: Meling, G. I., et al.
Publicado: (1991)

Taxonomic composition and biodiversity of the gut microbiome from patients with irritable bowel syndrome, ulcerative colitis, and asthma
por: Tikunov, A.Y., et al.
Publicado: (2021)

Remission of ulcerative colitis flare-up induced by nivolumab
por: Iwamoto, Maho, et al.
Publicado: (2020)

Efficacy of FODMAP Elimination and Subsequent Blinded Placebo-Controlled Provocations in a Randomised Controlled Study in Patients with Ulcerative Colitis in Remission and Symptoms of Irritable Bowel Syndrome: A Feasibility Study
por: Melgaard, Dorte, et al.
Publicado: (2022)

Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBD
por: Więcek, Martyna, et al.
Publicado: (2022)

Ulcerative Colitis Activity Presenting as Fever of Unknown Origin, in a Patient with Longstanding Disease under Continuous Treatment with Mesalazine
por: Voukelatou, Panagiota, et al.
Publicado: (2016)

Endoscopic on-site characterization of a large excavated lesion in longstanding ulcerative colitis using a novel bioinformatic tool
por: Wagner, Andrej, et al.
Publicado: (2023)

Ulcerative colitis, Crohn’s disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn’s disease
por: Mortensen, Joachim Høg, et al.
Publicado: (2017)

Patients With Irritable Bowel Syndrome Exhale More Hydrogen Than Healthy Subjects in Fasting State
por: Kumar, Sunil, et al.
Publicado: (2010)

Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence?
por: Purssell, Huw, et al.
Publicado: (2021)

Prevalence and risk factors of bowel symptoms in Korean patients with ulcerative colitis in endoscopic remission: a retrospective study
por: Nam, Kwangwoo, et al.
Publicado: (2021)

Sa078 CLINICAL AND LABORATORY MARKERS DO NOT PREDICT DEEP HISTOLOGIC REMISSION IN PATIENTS WITH ULCERATIVE COLITIS
por: Sharma, Disha, et al.
Publicado: (2021)

Correlation of Biomarkers with Endoscopic Score: Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in Patients with Ulcerative Colitis in Remission
por: Pop, Corina Silvia, et al.
Publicado: (2020)

Rapid Induction and Maintenance of Remission in Refractory Ulcerative Colitis with Ustekinumab
por: Chen, An-Yu, et al.
Publicado: (2019)

Real-life evaluation of histologic scores for Ulcerative Colitis in remission
por: Arkteg, Christian Børde, et al.
Publicado: (2021)

Analysis of Endoscopic Evaluation Reliability for Ulcerative Colitis in Histological Remission
por: Kanazawa, Mimari, et al.
Publicado: (2021)

Multiple Granulocytic Sarcomas in a Patient with Longstanding Complete Remission of Acute Myelogenous Leukemia
por: Jung, Hee-Dam, et al.
Publicado: (2011)

Reduced hTERT protein levels are associated with DNA aneuploidy in the colonic mucosa of patients suffering from longstanding ulcerative colitis
por: FRIIS-OTTESSEN, MARIANN, et al.
Publicado: (2014)

Peripheral blood leukocytes express differential chemokine receptor profiles in irritable bowel syndrome, Crohn’s disease and ulcerative colitis
por: Linton, Ludvig, et al.
Publicado: (2012)

Early Clinical Remission Is a Predictor of Long-Term Remission with the Use of Vedolizumab for Ulcerative Colitis
por: Haga, Keiichi, et al.
Publicado: (2022)

Is Rome III Criteria for Irritable Bowel Syndrome More Useful Than Rome II Criteria in Korea?
por: Park, Moo In
Publicado: (2010)

Clinical Efficacy of Probiotic Therapy on Bowel-Related Symptoms in Patients with Ulcerative Colitis during Endoscopic Remission: An Observational Study
por: Lee, Jin, et al.
Publicado: (2022)

Exploring Disease Remission and Bowel Urgency Severity Among Adults with Moderate to Severe Ulcerative Colitis: A Qualitative Study
por: Dubinsky, Marla C, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bdnrdof4in4c9s933unh5bkio3